Inventor · Austin, TX, US

John J. Koleng

27Patents
6h-index
30Co-inventors
69Inventor score

Filing activity: Jun 17, 2002 → Feb 6, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US6509028B2 Methods and compositions for treating pain of the mucous membrane Human Necessities 79 Expired
US8394434B2 SCF extract containing cardiac glycoside Human Necessities 23 Active
US9795559B2 Intranasal dexmedetomidine compositions and methods of use thereof Human Necessities 17 Active
US8173152B2 Stabilized compositions containing alkaline labile drugs Human Necessities 16 Active
US10961191B2 Formulation for soft anticholinergic analogs Human Necessities 7 Active
US10959983B2 Formulation for soft anticholinergic analogs Human Necessities 6 Active
US10947192B2 Formulation for soft anticholinergic analogs Human Necessities 6 Active
US11084788B2 Formulation for soft anticholinergic analogs Human Necessities 6 Active
US11034652B2 Formulation for soft anticholinergic analogs Human Necessities 6 Active
US11052067B2 Formulation for soft anticholinergic analogs Human Necessities 6 Active
US10952990B2 Formulation for soft anticholinergic analogs Chemistry; Metallurgy 3 Active
US11160869B2 Compositions, formulations and interleukin production and purification Emerging Cross-Sectional Technologies 3 Active
US11123325B2 Formulation for soft anticholinergic analogs Human Necessities 3 Active
US11026919B2 Formulation for soft anticholinergic analogs Chemistry; Metallurgy 3 Active
US8465759B2 Process for the preparation of a hot-melt extruded laminate Performing Operations; Transporting 2 Active
US10682311B2 Intranasal dexmedetomidine compositions and methods of use thereof Human Necessities 1 Active
US8883187B2 Stabilized compositions containing alkaline labile drugs Human Necessities 1 Active
US9364445B2 Stabilized compositions containing alkaline labile drugs Human Necessities 1 Active
US11787838B2 Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis Chemistry; Metallurgy 0 Active
US12156865B2 Formulation for soft anticholinergic analogs Human Necessities 0 Active
US9867786B2 Stabilized compositions containing alkaline labile drugs Human Necessities 0 Active
US12357609B2 Formulation for soft anticholinergic analogs Chemistry; Metallurgy 0 Active
US12280089B2 Dry powder formulation of caveolin-1 peptides and methods of use thereof Chemistry; Metallurgy 0 Active
US12280088B2 Dry powder formulation of caveolin-1 peptides and methods of use thereof Chemistry; Metallurgy 0 Active
US11905336B2 Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.